Fengler Justin (CIK 2149552) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-15). Recent activity: Buy GDRX (2,335 shares), Sell GDRX (1,024 shares), Buy GDRX (752 shares), Sell GDRX (330 shares), Buy GDRX (10,149 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Buy | 2,335 | $0 |
| 2026-09-15 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Sell | 1,024 | $3,645 |
| 2026-09-15 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Buy | 752 | $0 |
| 2026-09-15 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Sell | 330 | $1,175 |
| 2026-08-17 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Buy | 10,149 | $0 |
| 2026-08-17 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Sell | 4,575 | $17,065 |
| 2026-08-17 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Buy | 6,423 | $0 |
| 2026-08-17 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Sell | 2,817 | $10,507 |
| 2026-08-17 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Buy | 6,392 | $0 |
| 2026-08-17 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Sell | 2,803 | $10,455 |
| 2026-08-17 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Buy | 25,568 | $0 |
| 2026-08-17 | GoodRx Holdings, Inc. (GDRX) | Chief Financial Officer and Chief Strategy & Operations Officer | Sell | 11,212 | $41,821 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15